Showing results (1471-1480 of 1,667) with videos related to

Sort By:
Pageof 167
Science (New York, N.Y.)|August 15, 2015
MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORγ⁺ regulatory T cellsEsen Sefik, Naama Geva-Zatorsky, Sungwhan Oh, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2021
A virus-specific monocyte inflammatory phenotype is induced by SARS-CoV-2 at the immune-epithelial interfaceJuliette Leon, Daniel A Michelson, Judith Olejnik, et al.
Cancer Treatment Reviews|June 15, 2021
Treatment breaks in first line treatment of advanced colorectal cancer: An individual patient data meta-analysisRichard Adams, Kaitlyn Goey, Benoist Chibaudel, et al.
Cancers|February 13, 2026
Prognostic Impact of Blood Tumor Mutational Burden in pMMR/MSS Metastatic Colorectal Cancer Assessed by FoundationOne® Liquid CDxBenoist Chibaudel, Elisabeth Carola, Hamid Mekranter, et al.
BMC Cancer|December 6, 2019
Multicenter phase III randomized trial comparing laparoscopy and laparotomy for colon cancer surgery in patients older than 75 years: the CELL study, a Fédération de Recherche en Chirurgie (FRENCH) trialGilles Manceau, Antoine Brouquet, Pascal Chaibi, et al.
Immunity|April 22, 2014
Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responsesNicole Joller, Ester Lozano, Patrick R Burkett, et al.
Immunity|November 21, 2024
A pan-family screen of nuclear receptors in immunocytes reveals ligand-dependent inflammasome controlYutao Wang, Yanbo Zhang, Kyungsub Kim, et al.
The Lancet. Oncology|November 7, 2025
Ezabenlimab and induction chemotherapy followed by adaptive chemoradiotherapy in patients with stage 3 squamous cell anal carcinoma (INTERACT-ION): an open-label, single-arm, phase 2 trialStefano Kim, Jihane Boustani, Soledad Iseas, et al.
The Journal of Molecular Diagnostics : JMD|October 17, 2021
Highly Sensitive Detection Method of Retinoblastoma Genetic Predisposition and BiomarkersJessica Le Gall, Catherine Dehainault, Camille Benoist, et al.
The Lancet. Gastroenterology & Hepatology|April 12, 2017
Nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil as first-line therapy for metastatic pancreatic adenocarcinoma (AFUGEM GERCOR): a non-comparative, multicentre, open-label, randomised phase 2 trialJean-Baptiste Bachet, Pascal Hammel, Jérôme Desramé, et al.
Pageof 167